Your browser doesn't support javascript.
loading
CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer.
Sun, Weilin; Wang, Xi; Wang, Daohan; Lu, Li; Lin, Hai; Zhang, Zhaoxiong; Jia, Yangpu; Nie, Xinyang; Liu, Tong; Fu, Weihua.
Afiliação
  • Sun W; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Wang D; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Lu L; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Lin H; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Zhang Z; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Jia Y; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Nie X; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu T; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China liutonga@126.com tjmughgs_fwh@163.com.
  • Fu W; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China liutonga@126.com tjmughgs_fwh@163.com.
J Immunother Cancer ; 10(7)2022 07.
Article em En | MEDLINE | ID: mdl-35851310
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article